Sign In
Buy ME
$0.606
+0 (+0%)
At Close: Sep 16, 2025
Got $2,500? Check Out These 2 Biotech 2.0 Stocks
06:27am, Thursday, 01'st Jul 2021
They're poised to disrupt the drug development process.
Is 23andMe a Buy at $11?
07:18am, Tuesday, 29'th Jun 2021
Yes, but it'll take a while to grow with gusto.
2 Growth Stocks to Put on Your Radar
06:38am, Thursday, 24'th Jun 2021
Here are two stocks our experts are keeping their eye on right now.
Can You Count on 23andMe Stock?
05:18am, Thursday, 24'th Jun 2021
This innovative consumer genetic testing company is more than meets the eye.
Industry Leaders Join 23andMe Board of Directors
08:00am, Monday, 21'st Jun 2021
Dr. Valerie Montgomery Rice and Peter Taylor Join 23andMe's Board as the Company Sets to Accelerate Personalized Healthcare Based on Human Genetics Dr. Valerie Montgomery Rice and Peter Taylor Join 23
23andMe CEO on public debut, future of genetic testing
12:20pm, Saturday, 19'th Jun 2021
This segment originally aired on June 17, 2021. DNA testing company 23andMe started trading on Thursday, under the ticker ‘ME'.
ME Stock Price Increased 21.2% In Market Debut: Details
08:40am, Friday, 18'th Jun 2021
The stock price of 23andMe Holding Co. (NASDAQ: ME) increased by 21.2% in its market debut yesterday. These are the details.
DNA Testing Company 23andMe Makes Nasdaq Debut
04:15pm, Thursday, 17'th Jun 2021
Consumer genetic testing company 23andMe has made its Nasdaq debut at about $11 a share. CEO Anne Wojcicki joined Cheddar to talk about taking the company public through a SPAC merger.
IPO Report: 23andMe shares surge 17% in their trading debut after merger with Richard Branson-backed SPAC
02:14pm, Thursday, 17'th Jun 2021
Shares of consumer genetics company 23andMe rose about 17% in their trading debut Thursday, after the provider of home DNA test kits went public via a merger with Richard Branson's special-purpose acq
Genetic testing company 23andMe rises in first trade after Richard Branson SPAC merger
12:47pm, Thursday, 17'th Jun 2021
23andMe, a genetic testing start-up that pioneered personalized medicine as a consumer business, trades under ticker "ME" in a deal with Richard Branson's SPAC.
23andMe to go public on NASDAQ under ticker symbol 'Me'
12:15pm, Thursday, 17'th Jun 2021
Myles Udland, Brian Sozzi, and Julie Hyman breakdown 23andMe going public with the help of Richard Branson, and how the company plans to change its business model to make itself more profitable in the
